Tefron Ltd.
TFRFF
$6.43
-$0.03-0.46%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -19.26% | -15.87% | -3.40% | 5.02% | 20.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.26% | -15.87% | -3.40% | 5.02% | 20.70% |
| Cost of Revenue | -17.04% | -13.34% | -2.42% | 5.83% | 20.74% |
| Gross Profit | -26.87% | -24.35% | -6.69% | 2.26% | 20.56% |
| SG&A Expenses | -8.29% | -4.22% | 5.91% | 11.69% | 19.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -37.87% | -4.34% | -4.34% | -4.34% | -4.34% |
| Total Operating Expenses | -15.43% | -11.75% | -1.10% | 6.75% | 20.56% |
| Operating Income | -64.13% | -60.45% | -28.04% | -13.99% | 22.40% |
| Income Before Tax | -74.33% | -66.85% | -27.38% | -11.19% | 35.30% |
| Income Tax Expenses | -47.54% | -66.56% | -42.93% | -28.56% | 26.23% |
| Earnings from Continuing Operations | -82.21% | -66.94% | -22.60% | -5.35% | 38.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -82.21% | -66.94% | -22.60% | -5.35% | 38.22% |
| EBIT | -64.13% | -60.45% | -28.04% | -13.99% | 22.40% |
| EBITDA | -50.97% | -48.76% | -22.09% | -8.45% | 20.99% |
| EPS Basic | -82.02% | -67.07% | -23.07% | -7.92% | 35.43% |
| Normalized Basic EPS | -74.03% | -66.97% | -27.77% | -13.51% | 32.85% |
| EPS Diluted | -82.59% | -66.83% | -23.48% | -9.25% | 32.31% |
| Normalized Diluted EPS | -74.06% | -66.25% | -27.82% | -14.34% | 30.35% |
| Average Basic Shares Outstanding | -1.34% | 1.11% | 0.98% | 2.63% | 2.26% |
| Average Diluted Shares Outstanding | -4.08% | -3.38% | -0.03% | 2.55% | 3.41% |
| Dividend Per Share | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 4.81% | 2.12% | 0.33% | -- | -- |